This is where the staff of the Reeve Foundation is sharing up-to-the-minute information and putting some context around the news affecting the spinal cord injury and paralysis community. Not to mention insight into what's going on here at the Foundation.
Feel free to comment and offer suggestions. We'll respond.
A second US company, StemCells Inc., announced plans Novmeber 15th for a spinal cord injury clinical trial exploring the safety of human stem cells. These particular cells are purified human neural cells derived from fetal tissue and the StemCells Inc. Phase I will enroll patients who are between three and 12 months post-injury.
Dr. Aileen Anderson, a StemCells Inc. collaborator, first published the results of her spinal cord studies in PNAS in 2005 (Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice, Brian J. Cummings, Nobuko Uchida, Stanley J. Tamaki, Desiree L. Salazar, Mitra Hooshmand, Robert Summers, Fred H. Gage and Aileen J. Anderson). This was followed in 2010 by a Plos One publication in a model of early chronic injury, Human Neural Stem Cells Differentiate and Promote Locomotor Recovery in an Early Chronic Spinal coRd Injury NOD-scid Mouse Model (Desiree L. Salazar, Nobuko Uchida, Frank P.T. Hamers, Brian J. Cummings, Aileen J. Anderson).
Dr. Anderson, an Associate Professor in the Departments of Physical Medicine and Rehabilitation, and Anatomy and Neurobiology at the University of California, Irvine, is also Scientific Director of the Reeve Foundation's Injury Core Laboratory there.
Read more about it in the OC Register.
Stem Cells, Inc. press release.
Susan P. Howley
Executive Vice President, Research
Christopher and Dana Reeve Foundation